|
FDA approves Eliquis to reduce the risk of stroke, blood clots in patients with non-valvular atrial fibrillation
|
01 January 2013 |
|
FDA expands use of Xarelto to treat, reduce recurrence of blood clots
|
04 November 2012 |
|
FDA takes action against thousands of illegal Internet pharmacies
|
04 October 2012 |
|
FDA approves new treatment for advanced colorectal cancer
|
27 September 2012 |
|
New FDA task force will support innovation in antibacterial drug development
|
24 September 2012 |
|
FDA approves Lucentis to treat diabetic macular edema
|
12 August 2012 |
|
FDA approves first generic versions of Singulair to treat asthma, allergies
|
05 August 2012 |
|
More than 150 antiretroviral drugs available through PEPFAR for worldwide HIV/AIDS relief
|
24 July 2012 |
|
FDA approves generic versions of blood thinner Plavix
|
21 May 2012 |
|
FDA issues alert on potential dangers of unproven treatment for multiple sclerosis
|
11 May 2012 |
|
FDA approves first Boniva generics to treat or prevent osteoporosis
|
19 March 2012 |
|
FDA announces safety changes in labeling for some cholesterol-lowering drugs
|
28 February 2012 |
|
FDA acts to bolster supply of critically needed cancer drugs
|
22 February 2012 |
|
FDA approves first generic version of cholesterol-lowering drug Lipitor
|
01 December 2011 |
|
Drug not Shown to be Safe and Effective in Breast Cancer Patients
|
21 November 2011 |
|
FDA begins process to remove breast cancer indication from Avastin label
|
16 December 2010 |
|
FDA warns consumers not to use Vigor-25
|
21 November 2010 |
|
FDA: Include warnings on risk for class of prostate cancer drugs
|
25 October 2010 |
|
FDA: Possible increased risk of thigh bone fracture with bisphosphonates
|
14 October 2010 |
|
FDA issues final rule on safety information during clinical trials
|
29 September 2010 |